JPWO2022138758A1 - - Google Patents
Info
- Publication number
- JPWO2022138758A1 JPWO2022138758A1 JP2022571581A JP2022571581A JPWO2022138758A1 JP WO2022138758 A1 JPWO2022138758 A1 JP WO2022138758A1 JP 2022571581 A JP2022571581 A JP 2022571581A JP 2022571581 A JP2022571581 A JP 2022571581A JP WO2022138758 A1 JPWO2022138758 A1 JP WO2022138758A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020217745 | 2020-12-25 | ||
PCT/JP2021/047681 WO2022138758A1 (ja) | 2020-12-25 | 2021-12-22 | 標的抗原の測定方法並びにそれに用いる不溶性粒子及び標的抗原測定用キット |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2022138758A1 true JPWO2022138758A1 (ja) | 2022-06-30 |
Family
ID=82157013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022571581A Pending JPWO2022138758A1 (ja) | 2020-12-25 | 2021-12-22 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20240060970A1 (ja) |
EP (1) | EP4261221A1 (ja) |
JP (1) | JPWO2022138758A1 (ja) |
CN (1) | CN116601168A (ja) |
WO (1) | WO2022138758A1 (ja) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08220099A (ja) * | 1995-02-10 | 1996-08-30 | Morinaga Milk Ind Co Ltd | 物質の検出試薬及び慢性関節リウマチの検知法 |
EP1686176A1 (en) | 2005-01-28 | 2006-08-02 | Icon Genetics AG | Production of antibodies in plants with plus-sense single-stranded viral RNA vectors |
JP4330025B2 (ja) | 2007-12-28 | 2009-09-09 | 古河電気工業株式会社 | 多糖を表面に有する複合粒子、複合粒子コロイド、それを用いた分析試薬、及び複合粒子の製造方法 |
JP6740083B2 (ja) | 2015-10-23 | 2020-08-12 | 株式会社Lsiメディエンス | 免疫学的測定試薬、測定方法及び測定範囲の拡大方法 |
GB201700553D0 (en) * | 2017-01-12 | 2017-03-01 | Genagon Therapeutics Ab | Therapeutic agents |
JP6870851B2 (ja) * | 2017-05-12 | 2021-05-12 | 国立研究開発法人農業・食品産業技術総合研究機構 | 機能的な一本鎖抗体の製造方法 |
CA3059472A1 (en) * | 2017-05-19 | 2018-11-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibody targeting tnfr2 for cancer immunotherapy |
-
2021
- 2021-12-22 US US18/269,257 patent/US20240060970A1/en active Pending
- 2021-12-22 EP EP21910898.2A patent/EP4261221A1/en active Pending
- 2021-12-22 JP JP2022571581A patent/JPWO2022138758A1/ja active Pending
- 2021-12-22 WO PCT/JP2021/047681 patent/WO2022138758A1/ja active Application Filing
- 2021-12-22 CN CN202180084916.8A patent/CN116601168A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022138758A1 (ja) | 2022-06-30 |
US20240060970A1 (en) | 2024-02-22 |
EP4261221A1 (en) | 2023-10-18 |
CN116601168A (zh) | 2023-08-15 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230426 |